Table 7.
Cathepsin K immunohistochemical expression concerning the different TNM clinical stages using Pearson chi-square test
| TNM clinical stage | Cathepsin K | Total | Pearson Chi-Square Asymp. Sig. (2-sided) | |
|---|---|---|---|---|
| negative or weak expression | moderate or strong expression | |||
|
stage I + II % within TNM clinical stage |
10 | 3 | 13 | .000 |
| 76.9% | 23.1% | 100.0% | ||
|
stage III + IV % within TNM clinical stage |
6 | 26 | 32 | |
| 18.8% | 81.3% | 100.0% | ||
|
Total % within TNM clinical stage |
16 | 29 | 45 | |
| 35.6% | 64.4% | 100.0% | ||
The mean difference is significant at the 0.05 level, Pearson Chi square test